Why Is Fertility Treatment-Focused Firm INVO Bioscience Stock Trading Over 100% Higher Today?

INVO Bioscience Inc INVO announced that it is soliciting waivers from holders of the company’s common stock purchase warrants dated August 8, 2023, of the holder’s right to exercise a cash payment option upon consummation of the previously announced proposed merger with NAYA Biosciences Inc.…#nayabiosciencesinc #receipt #nayabiosciences #invo #danielteper #waiversolicitation #warrants #noticeofwaiver #warrantsolicitation #newyorkcity
Source: Reuters: Health - Category: Consumer Health News Source Type: news